PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

Discovery of a new approach to inhibiting a highly treatment-refractory liver cancer

The approach could pave the way for combination therapies, including chemotherapy and immune checkpoint blockade.

2021-01-12
(Press-News.org) BOSTON -- Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital (MGH) have found. This new treatment for a disease with extremely poor outcomes uses antibodies to block placental growth factor (PlGF), a member of the vascular endothelial growth factor (VEGF) family, which has been widely studied for its role in new vessel formation in cancers. PlGF is highly expressed in ICC compared to normal liver tissue, and blocking it reduces the production of connective tissue while increasing the efficacy of chemotherapy and survival in mice with ICC. These findings were reported in Gut, the journal of the British Society of Gastroenterology.

"We were able to demonstrate that PlGF is a mediator of ICC progression, and that antibody blockade of PlGF in ICC models inhibited the activity of cancer-associated fibroblasts (CAFs), which produce connective tissue and also provide ICC cells with pro-survival and pro-invasion signals," says Dan G. Duda, DMD, PhD, director of Translational Research in GI Radiation Oncology at MGH, and senior author of the study. "Our findings suggest that PlGF inhibition is a potential therapeutic target that could have implications for other emerging combination therapies that have shown promise against ICC, a largely intractable disease with a dismal prognosis."

ICC is an aggressive cancer of the liver with a five-year survival rate of 15% for patients with early-stage disease, and 6% for those with metastases to regional lymph nodes. The cancer is characterized by vascular abnormalities, abundant connective tissue (known as desmoplasia) produced by activated CAFs, and few therapeutic options. Systemic chemotherapy using gemcitabine and cisplatin remains the standard of care for patients with advanced ICC, but the benefits are limited. "New therapies are urgently needed as incidence of ICC grows at 3% a year in the U.S. and worldwide," emphasizes Duda.

The MGH study was inspired by previous research by Duda and Rakesh K. Jain, PhD, director of the Edwin L. Steele Laboratories for Tumor Biology at MGH, and a pioneer in the fields of tumor microenvironment and cancer therapy, that identified PlGF as a potential target to inhibit the growth and spread of medulloblastoma, the most common pediatric malignant brain tumor. Their groundbreaking research demonstrated high expression of the PlGF receptor neuropilin 1 (Nrp1) in medulloblastoma and found that PlGF/Nrp1 blockade resulted in tumor regression, decreased metastasis, and increased survival in mice. PlGF blockade using antibodies has been tested in a phase 1 clinical trial (ClinicalTrials.gov Identifier: NCT02748135) with final results to be reported later this year.

"Our prior work led us to study other cancers where PlGF might play a pivotal role," notes Duda. "We found that PlGF levels were also elevated in CAFs and circulating blood plasma in ICC patients, and were associated with disease progression." Investigation in mouse models further revealed that PlGF blockade reduced desmoplasia and tissue stiffness, which are determinants of tumor aggressiveness and resistance to treatment. Consequently, the antibody blockade re-opened collapsed tumor vessels and improved blood perfusion and chemotherapy efficacy, while reducing ICC cell invasion and increasing survival in mice. "In effect, we reprogrammed the hypoxic tumor microenvironment, which could have major implications for novel combination therapies targeting ICC or other highly desmoplastic tumors, such as pancreatic cancer," explains Jain, co-author of the latest study.

Such a systemic approach could enhance the efficacy of standard chemotherapy but also radiation therapy or immune checkpoint inhibitors, including programmed cell death 1 (PD-1) blockade - all of which have shown promise against ICC. "Our results indicate that PlGF blockade can provide a clinical strategy for growing numbers of ICC patients who have failed to see any significant improvements in treatment over the years," says Duda.

INFORMATION:

Duda is an associate professor of Radiation Oncology at Harvard Medical School (HMS). Jain is Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology) at HMS. The MGH team of researchers included lead authors Shuichi Aoki, MD, PhD, and Koetsu Inoue, MD, PhD, from the Edwin L. Steele Laboratories for Tumor Biology, and co-author Andrew X. Zhu, MD, PhD, director emeritus of Liver Cancer Research at the MGH Cancer Center and a professor of Medicine at HMS.

The study was supported by the National Institutes of Health (NIH) and the Cholangiocarcinoma Foundation.

About the Massachusetts General Hospital Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America's Best Hospitals."



ELSE PRESS RELEASES FROM THIS DATE:

UCF researchers use advanced light to reveal how different biofuels behave

2021-01-12
ORLANDO, Jan. 12, 2021 -Vehicles have evolved to become more efficient and sophisticated, but their fuel hasn't necessarily evolved along with them. The Department of Energy is determined to identify cleaner burning and renewable alternatives to gasoline, and through the work of two UCF researchers, the DOE is one step closer to that goal. Research engineer Anthony C. Terracciano and Associate Professor Subith Vasu have developed a model that will help engine designers, fuel chemists and federal agencies determine whether certain biofuels should be implemented as an alternative fuel ...

How many tests after vasectomy? Guideline update leads to change in practice

2021-01-12
January 12, 2021 - A change in evidence-based guidelines for vasectomy may have led to a reduction in the number of follow-up tests to confirm the procedure was successful, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. Originally published in 2012, and then updated in 2015, the AUA clinical guideline could significantly reduce the number of men undergoing multiple postvasectomy semen analyses (PVSAs) to confirm it's safe to stop using other methods of birth control, according to new research by Tony Chen, MD, of University of Washington, ...

Soil degradation costs U.S. corn farmers a half-billion dollars every year

Soil degradation costs U.S. corn farmers a half-billion dollars every year
2021-01-12
One-third of the fertilizer applied to grow corn in the U.S. each year simply compensates for the ongoing loss of soil fertility, leading to more than a half-billion dollars in extra costs to U.S. farmers every year, finds new research from the University of Colorado Boulder published last month in Earth's Future. Long-term soil fertility is on the decline in agricultural lands around the world due to salinization, acidification, erosion and the loss of important nutrients in the soil such as nitrogen and phosphorus. Corn farmers in the U.S. offset these losses with nitrogen and ...

Enlightening dark ions

2021-01-12
Every field has its underlying principles. For economics it's the rational actor; biology has the theory of evolution; modern geology rests on the bedrock of plate tectonics. Physics has conservation laws and symmetries. For instance, the law of conservation of energy - which holds that energy can neither be created nor destroyed -- has guided research in physics since antiquity, becoming more formalized as time went on. Likewise, parity symmetry suggests that switching an event for its mirror image shouldn't affect the outcome. As physicists have worked to understand the truly bizarre rules ...

Study of flowers with two types of anthers solves mystery that baffled Darwin

Study of flowers with two types of anthers solves mystery that baffled Darwin
2021-01-12
Most flowering plants depend on pollinators such as bees to transfer pollen from the male anthers of one flower to the female stigma of another flower, enabling fertilization and the production of fruits and seeds. Bee pollination, however, involves an inherent conflict of interest, because bees are only interested in pollen as a food source. "The bee and the plant have different goals, so plants have evolved ways to optimize the behavior of bees to maximize the transfer of pollen between flowers," explained Kathleen Kay, associate professor of ecology ...

High doses of saccharin don't lead to diabetes in healthy adults, study finds

2021-01-12
COLUMBUS, Ohio - For those trying to live a healthy lifestyle, the choice between sugar and artificial sweeteners such as saccharin can be confusing. A new study led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine found the sugar substitute saccharin doesn't lead to the development of diabetes in healthy adults as previous studies have suggested. The study findings are published in the journal Microbiome. "It's not that the findings of previous studies are wrong, they just didn't adequately control for things like ...

Scientists identify "immune cop" that detects SARS-CoV-2

Scientists identify immune cop that detects SARS-CoV-2
2021-01-12
LA JOLLA, CALIF. - Jan 12, 2020 - Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified the sensor in human lungs that detects SARS-CoV-2 and signals that it's time to mount an antiviral response. The study, published today in Cell Reports, provides insights into the molecular basis of severe disease and may enable new strategies for the treatment and prevention of COVID-19. "Our research has shown that MDA-5 is the immune cop that's tasked to keep an eye out for SARS-CoV-2 and call for back-up," says Sumit Chanda, Ph.D., director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys and senior author of ...

Family court decisions distorted by misuse of key research, say experts

2021-01-12
Family courts are misunderstanding and misusing research around how children form close relationships with their caregivers, say an international group of experts. Seventy experts from across the globe argue that widespread misunderstandings around attachment research have hampered its accurate implementation, with potentially negative consequences for decisions in family courts. In response, they have published an international consensus statement in Attachment & Human Development that aims "to counter misinformation and help steer family court applications of attachment theory in a supportive, evidence-based direction on matters related to child protection and custody decisions". In the statement, the group sets out three principles from attachment research ...

Noted experts challenge conventional wisdom within the field of radiology

2021-01-12
Philadelphia, January 12, 2021 - A special issue of the Journal of the American College of Radiology (JACR), published by Elsevier, challenges conventional wisdom across the imaging community. This collection of articles, the "Provocative Issue," presents extreme opinions on pressing issues confronting radiologists with the deliberate aim of sparking positive dialog and debate that will lead to innovative solutions to improve patient care and imaging-related outcomes. The issue is guest-edited by: Caroline Chung, MD, MSc, Director of Advanced ...

Record drop in cancer mortality for second straight year due to improved lung cancer treatment

2021-01-12
ATLANTA - JANUARY 12, 2021 - Overall cancer death rates in the United States dropped continuously from 1991 through 2018 for a total decrease of 31%, including a 2.4% decline from 2017 to 2018. The news comes from the American Cancer Society's annual Cancer Statistics, 2021 article, appearing in CA: A Cancer Journal for Clinicians, and its consumer version, Cancer Facts & Figures 2021. This year marks the American Cancer Society's 70th anniversary of reporting this data to inform the nation's fight against cancer. The report estimates that in the U.S. in 2021, almost 1.9 million (1,898,160) new cancer cases will be diagnosed and 608,570 Americans will die from cancer. ...

LAST 30 PRESS RELEASES:

Childhood cancer survivors are not more likely to terminate their pregnancies

Fine tuning first-responder immune cells may reduce TBI damage

Efficient solid-state depolymerization of waste PET

Women influenced coevolution of dogs and humans

Doctoral student leads paleoclimate study of precipitation and sea ice in Arctic Alaska

Continued strict control measures needed to reduce new COVID-19 strains

The Lancet: World failing to address health needs of 630 million women and children affected by armed conflict

Dramatic changes to radiotherapy treatments due to COVID-19

UTMB team proves potential for reducing pre-term birth by treating fetus as patient

New technique builds super-hard metals from nanoparticles

Regulating the ribosomal RNA production line

ECMO/CRRT in the treatment of critically ill SARS-CoV-2 pneumonia patients

Risk factors for intraoperative pressure injury in aortic surgery

Predictive value of blood pressure, heart rate, and blood pressure/heart rate ratio in a Chinese subpopulation with vasovagal syncope

A method for calculating optimal parameters of liquid chrystal displays developed at RUDN University

No more needles for diagnostic tests?

A professor from RUDN University developed new liquid crystals

Wet and wild: There's lots of water in the world's most explosive volcano

Exercising muscle combats chronic inflammation on its own

From fins to limbs

UK public supports usage of tracking technology and immunity passports in global pandemic

Climate and carbon cycle trends of the past 50 million years reconciled

Crystal structures in super slow motion

University of Cincinnati research unveils possible new combo therapy for head and neck cancer

NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests

Tiny particles that seed clouds can form from trace gases over open sea

Experts call for more pragmatic approach to higher education teaching

A quarter of known bee species haven't appeared in public records since the 1990s

AI trained to read electric vehicle charging station reviews to find infrastructure gaps

Genetic sequence for parasitic flowering plant Sapria

[Press-News.org] Discovery of a new approach to inhibiting a highly treatment-refractory liver cancer
The approach could pave the way for combination therapies, including chemotherapy and immune checkpoint blockade.